BNKL Bionik Laboratories Corp

USD 0.10 0.00 0
Icon

Bionik Laboratories Corp (BNKL) Stock Analysis and Price Targets

COMMON STOCK | Medical Care Facilities | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.1

0.00 (0.00)%

USD 12.00

N/A

N/A

N/A

Icon

BNKL

Bionik Laboratories Corp (USD)
COMMON STOCK | OTC
USD 0.10
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 12.00

N/A

USD 0.10

Bionik Laboratories Corp (BNKL) Stock Forecast

N/A

Based on the Bionik Laboratories Corp stock forecast from 0 analysts, the average analyst target price for Bionik Laboratories Corp is not available over the next 12 months. Bionik Laboratories Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bionik Laboratories Corp is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Bionik Laboratories Corp’s stock price was USD 0.1. Bionik Laboratories Corp’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -71.43% over the last year.

No recent analyst target price found for Bionik Laboratories Corp
No recent average analyst rating found for Bionik Laboratories Corp

Company Overview Bionik Laboratories Corp

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM...Read More

https://www.bioniklabs.com

80 Coolidge Hill Road, Watertown, MA, United States, 02472

12

March

USD

USA

Adjusted Closing Price for Bionik Laboratories Corp (BNKL)

Loading...

Unadjusted Closing Price for Bionik Laboratories Corp (BNKL)

Loading...

Share Trading Volume for Bionik Laboratories Corp Shares

Loading...

Compare Performance of Bionik Laboratories Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BNKL

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bionik Laboratories Corp (Sector: Medical Care Facilities )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
FSNUF
Fresenius SE & Co. KGaA -1.22 (-4.37%) USD15.72B 40.45 11.00

ETFs Containing BNKL

Symbol Name BNKL's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Bionik Laboratories Corp (BNKL) Stock

Stock Target Advisor's fundamental analysis for Bionik Laboratories Corp's stock is Bearish.

Unfortunately we do not have enough data on BNKL's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BNKL's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BNKL's stock to indicate if its overvalued.

The last closing price of BNKL's stock was USD 0.10.

The most recent market capitalization for BNKL is USD 12.00.

Unfortunately we do not have enough analyst data on BNKL's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Bionik Laboratories Corp's stock.

As per our most recent records Bionik Laboratories Corp has 12 Employees.

Bionik Laboratories Corp's registered address is 80 Coolidge Hill Road, Watertown, MA, United States, 02472. You can get more information about it from Bionik Laboratories Corp's website at https://www.bioniklabs.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...